IBP:NYSEInstalled Building Products, Inc. Analysis
Data as of 2026-04-09 - not real-time
$281.25
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Installed Building Products is trading at $281.25, comfortably above its 200‑day SMA (≈$263) but still below the 50‑day SMA (≈$298), indicating a neutral to slightly bullish medium‑term bias. Momentum indicators are mixed – the RSI sits near 51 (neutral) while the MACD histogram is positive, signaling short‑term bullish pressure. The stock carries a forward PE of ~23x and a trailing PE of ~29x, well above the sector average, and a price‑to‑book of over 10x, suggesting the market is pricing in strong growth expectations. Fundamentally, the company posts an impressive ROE of ~37% and a solid dividend yield of 1.17% with a payout ratio under 33%, supporting dividend sustainability.
Recent earnings beat estimates and the announcement of three acquisitions adding >$22 million of annual revenue have reinforced optimism, reflected in analyst median price targets around $310 – roughly a 10% upside. However, high 30‑day volatility (~49%), a beta above 1, and a debt‑to‑equity ratio exceeding 130% raise concerns about risk, especially given the consumer‑cyclical nature of the residential construction sector.
Recent earnings beat estimates and the announcement of three acquisitions adding >$22 million of annual revenue have reinforced optimism, reflected in analyst median price targets around $310 – roughly a 10% upside. However, high 30‑day volatility (~49%), a beta above 1, and a debt‑to‑equity ratio exceeding 130% raise concerns about risk, especially given the consumer‑cyclical nature of the residential construction sector.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Positive MACD histogram and earnings beat signal near‑term strength
- Current price near resistance level (~$292) limits upside
- High volatility and decreasing volume increase short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Acquisition‑driven revenue expansion adding >$22 M annually
- Analyst median target of $310 implies ~10% upside
- Strong ROE and sustainable dividend support valuation premium
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistently high profitability margins and cash flow generation
- Dividend yield with low payout ratio offers income stability
- Diversified product portfolio mitigates cyclical housing slowdown risk
Key Metrics & Analysis
Financial Health
Revenue Growth-0.40%
Profit Margin8.93%
P/E Ratio28.9
ROE37.51%
ROA11.77%
Debt/Equity139.70
P/B Ratio10.6
Op. Cash Flow$371.4M
Free Cash Flow$305.4M
Technical Analysis
TrendNeutral
RSI50.8
Support$252.58
Resistance$292.09
MA 20$271.55
MA 50$298.29
MA 200$262.70
MACDBullish
VolumeDecreasing
Fear & Greed Index84.13
Valuation
Fair Value$127.61
Target Price$303.83
Upside/Downside8.03%
GradeOvervalued
TypeGrowth
Dividend Yield1.17%
Risk Assessment
Beta1.17
Volatility48.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.